Who pays for the 1000 dollar pill?
Innovation is expensive. And so is healthcare delivery. Who ultimately pays the price for our healthcare? While trying to manage the growing burden of chronic disease, aging populations, and rising costs payers face difficult decisions on how to manage their limited healthcare budgets. Should payers – government or private – put caps on what they’ll pay for cost-effective care? Is this type of quantification and valuation possible? Is it ethical? Will it kill innovation?